首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   678篇
  免费   41篇
  国内免费   9篇
儿科学   17篇
妇产科学   15篇
基础医学   42篇
临床医学   42篇
内科学   69篇
皮肤病学   3篇
神经病学   52篇
特种医学   34篇
外科学   292篇
综合类   80篇
预防医学   13篇
药学   31篇
中国医学   20篇
肿瘤学   18篇
  2023年   6篇
  2022年   23篇
  2021年   27篇
  2020年   20篇
  2019年   19篇
  2018年   25篇
  2017年   24篇
  2016年   29篇
  2015年   23篇
  2014年   52篇
  2013年   39篇
  2012年   39篇
  2011年   36篇
  2010年   38篇
  2009年   28篇
  2008年   43篇
  2007年   36篇
  2006年   35篇
  2005年   31篇
  2004年   23篇
  2003年   16篇
  2002年   12篇
  2001年   12篇
  2000年   16篇
  1999年   10篇
  1998年   8篇
  1997年   11篇
  1996年   7篇
  1995年   4篇
  1994年   4篇
  1993年   4篇
  1992年   4篇
  1991年   3篇
  1990年   1篇
  1989年   2篇
  1988年   2篇
  1987年   3篇
  1986年   3篇
  1985年   1篇
  1984年   2篇
  1982年   4篇
  1979年   1篇
  1978年   1篇
  1977年   1篇
排序方式: 共有728条查询结果,搜索用时 125 毫秒
1.
2.
前后挤压型骶骨Ⅱ区骨折与骶丛神经损伤的关系   总被引:1,自引:0,他引:1  
目的 探讨前后挤压致骶骨Ⅱ区骨折造成骶丛神经损伤的机制。方法 经甲醛短期(1年内)浸泡固定的国人尸体6具,12侧。解剖保护骶丛神经,制成前后挤压型暴力致骶Ⅱ区骨折模型,定量测量不同骨折移位时骶丛神经被拉长的距离。另外,利用X线片观察骶从神经受压情况。结果 随耻骨联合分离逐渐增大,骶丛神经张应变呈直线相关逐渐加大,以S1,S4为最显著,且可造成神经的刺伤,多见于L5和S1,X线未发现骶丛神经受压表现。结论 前后挤压型暴力致骶骨Ⅱ区骨折神经损伤以牵拉伤为丰,以S1,S4为主,且与骨折移位程度成正相关关系。神经的刺伤,多见于骨折移位较大的L5和S1。  相似文献   
3.
骶骨肿瘤的分区切除与重建方式的选择   总被引:2,自引:0,他引:2  
目的:探讨对骶骨肿瘤按其发生部位进行分区切除,选择相应重建方式的方法及疗效。方法:1988年2月-2005年1月手术治疗43例骶骨肿瘤患者,按肿瘤侵及部位(即上段骶骨、骶髂关节及骶髂关节水平向外的髂骨是否被破坏)对骶骨肿瘤进行分区切除并重建,相应的手术及重建方式包括单纯切除、钢针加塑形骨水泥(CPC)重建骶骨、钢板螺钉固定或骶骨螺钉固定重建骶髂关节、不同长度的Luque棒或髂骨棒加钢丝缠扎或TSRH或Isola或CGWS腰椎骨盆内固定。并给予相应的放疗与化疗。结果:术后出现脑脊液漏2例,切口感染及延期愈合3例,切口皮肤边缘坏死1例,下肢深静脉血栓形成1例,经积极处理后均治愈。随访1-17年,平均75个月,43例患者中39例(90.7%)术后疼痛得到缓解,视觉模拟疼痛评分由术前平均8.5分降低到术后3.4分(P〈0.01)。14例有神经功能损害的患者中,11例术后症状改善,3例无改善。20例行自体和或异体植骨的患者术后1年16例获得骨性融合。3例脊索瘤、3例恶性纤维组织细胞瘤和4例骨巨细胞瘤患者于术后1年因复发而进行1次或多次手术,其中有5例和1例骨髓瘤、1例转移癌患者于术后17-50个月因肺部和全身转移死亡。发生断棒2例,均再次手术更换断棒。结论:按肿瘤部位进行分区切除,选择相应的重建方式,达到尽可能广泛切除肿瘤组织和维持脊柱及骨盆稳定性的目的.是取得良好疗效的重要保证。  相似文献   
4.
Objective. We studied long‐term clinical efficacy of sacral neuromodulation (SNM) therapy in patients with refractory urgency incontinence (UI), urgency/frequency (UF) and voiding difficulty (VD), together with urodynamic data at baseline and six   months postimplant. Materials and Methods. Twenty‐two patients were implanted with a neurostimulator after a positive response to a percutaneous nerve evaluation test defined as a greater than 50% improvement in symptoms. Results. At five‐year follow‐up, the number of incontinent episodes and pad usage per day decreased significantly in 10 out of 15 UI patients. Two of five UF patients were successfully treated with SNM; the number of daily voids for all UF patients decreased from 25 to 19 and average voided volume increased from 98 to 212 mL. One of the two VD patients was able to void to completion. Mean first sensation of filling at the six‐month urodynamic investigation for the UI and UF patients increased from 78 to 241 mL and 141 to 232 mL, respectively, and the maximum bladder capacity increased from 292 to 352 mL and 223 to 318 mL, respectively. Five of 22 patients underwent device explant and one patient still has an inactive stimulator implanted. Conclusion. SNM is an effective treatment modality that offers sustained clinical benefit in the majority of patients with refractory UI, UF, and VD that do not respond to other, more conservative therapies.  相似文献   
5.
Summary BACKGROUND: Sacral nerve stimulation (SNS) is an option for the treatment of fecal incontinence in patients with morphologically intact, but weak external anal sphincter. METHODS: In ten patients a percutaneous test-SNS was performed. Two patients suffered from fecal incontinence after surgery, one patient after incomplete leg palsy after traumatic spine injury and seven patients from idiopathic incontinence. Incontinence score, anorectal manometry and patient diary were performed before and after test-SNS. RESULTS: Intraoperative response (Bellows action) could be achieved in 90% of patients. Test-SNS was successful in 50% of patients. In these patients, resting pressure was increased by 100.1% and squeeze pressure by 84.5%. CONCLUSIONS: SNS is an effective therapy in a subset of patients with fecal incontinence. Fifty percent of patients tested are eligible for implantation of a permanent stimulation device.   相似文献   
6.
目的:分析原发性骶骨肿瘤的病理学分型及影像学表现特点。方法:48例原发性骶骨肿瘤均经手术病理证实,术前均行常规X线平片、CT和/或MR检查,结合病理回顾分析了其影像学表现。结果:原发性骶骨肿瘤以脊索瘤(21例)最多见,其次是巨细胞瘤(7例)、神经源性肿瘤(6例)、软骨肉瘤(4例)、滑膜肉瘤(3例),囊肿(3例),其它相对少见,包括纤维组织细胞癌1例,尤文氏肉瘤1例,梭形细胞癌1例,节细胞神经瘤1例。影像表现包括软组织肿块、骶孔扩大、瘤灶内钙化、骨嵴形成等不同特点。常见原发骶骨肿瘤常有其特征性影像学表现。结论:原发骶骨肿瘤病理分型相对复杂,影像表现多样化,诊断常需综合不同影像检查手段。  相似文献   
7.
The subdivisions of the sacral intermediolateral nucleus (IML) of the cat have been studied by using a double-labeling technique of retrograde Fluoro-gold (FG) and wheat germ agglutinin-conjugated horseradish peroxidase (WGA-HRP) tracing. The parasympathetic preganglionic neurons (PGNs) that were labeled by the FG injected into the pelvic nerve formed a ‘V’-shaped column known as the sacral parasympathetic nucleus (SPN) in the sacral IML. The neurons that were labeled by the WGA-HRP applied to the lateral parabrachial nucleus (PBL) formed an elongated spindle-shaped column extending throughout the IML of the sacral segments. We designated it by the name of sacral visceral sensory nucleus (SVSN). These findings indicate that the sacral IML of the cat contain two distinct subdivisions, SPN and SVSN.  相似文献   
8.
Sacral insufficiency fractures develop over a period of time and show time-dependent changes. We report on 15 CT examinations of 5 patients with early-stage insufficiency fractures of the sacrum. In 4 patients only irregular sclerosis without distinct fracture lines was present in 7 of 8 fractures. Of these 4 patients; 3 exhibited intraosseous gas inclusions in a ventral part of a lateral mass; 5 of 8 fractures disclosed a ventral cortical break. When distinct fracture lines had developed in 1 patient, intraosseous vacuum phenomenon had disappeared. Fracture lines evolve over weeks to months and show central bone absorption. The fractures can heal as demonstrated in 4 of 6 fractures in 3 patients, can persist over 1 year without significant changes or can progress to pseudoarthrosis with bone destruction similar to neuropathic joint disease. Intraosseous vacuum phenomena can persist to this stage. Intraosseous vacuum phenomenon is recognized as a potential finding in the early stage of sacral insufficiency fracture, which also is true for irregular sclerosis and ventral cortical disruption. Correspondence to: A. Stäbler  相似文献   
9.
PURPOSES: In this study we present our experience with treating persistent sacral and perineal defects secondary to radiation and abdominoperineal resection with or without sacrectomy. METHODS: Fifteen consecutive patients were treated with an inferiorly based transpelvic rectus abdominis muscle or musculocutaneous flap. RESULTS: Fourteen of the 15 patients achieved healing, and 7 patients had no complications. The remaining eight patients required one or more operative debridements and/or prolonged wound care to accomplish a healed wound. Our technique for the dissection and insetting of the transpelvic muscle flap is presented. CONCLUSION: The difficult postirradiated perineal and sacral wounds can be healed with persistent surgical attention to adequate debridement, control of infections, and a well-vascularized muscle flap. The most satisfying aspects for patients are the discontinuance of foul-smelling discharge, discontinuation of multiple, daily dressing changes, and reduction in the degree of chronic pain.Read at the meeting of the Midwestern Association of Plastic Surgeons, Bismarck, North Dakota, June 15 to 18, 1992.  相似文献   
10.
目的:探讨骨盆环恶性肿瘤的切除、重建方式与并发症的处理 .方法:手术治疗骨盆环原发恶性或低度恶性肿瘤5例,其中骶骨恶性畸胎瘤2例、脊索瘤1例,髂骨骨肉瘤1例、恶性骨软骨瘤1例.所有患者术前未行动脉栓塞、结扎髂内血管.髂骨翼肿瘤采用自体髂骨、髋臼肿瘤采用异体骨重建骨盆环、自体股骨头重建髋臼骨床 人工全髋关节置换术.结果:5例肿瘤均行根治性切除,3例骶骨肿瘤术中出血量150~800 mL,术后出血300~1 000 mL,1例切口感染,1例术后出现失血性休克.髂骨翼肿瘤和髋臼周围肿瘤术中出血量分别为1 000 mL和4 000 mL,术后分别为800 mL和1 100 mL.髂骨肿瘤切除与重建患者2月后恢复关节功能,髋臼肿瘤切除与重建患者6月后恢复功能,4例患者术后随访4~24个月,生存良好.结论:骨盆环恶性肿瘤的外科手术治疗关键是完整的手术切除,包膜外切除可以减少出血、预防复发,影响骨盆环稳定时应考虑重建,自体、异体骨移植能够恢复髋臼周围骨量、维持骨盆环生物学稳定.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号